These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6659477)

  • 1. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
    Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
    Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
    Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to different tick-borne encephalitis vaccines as revealed by lymphocyte blast transformation and virus neutralization tests.
    Dzagurov SG; Vorobieva MS; Shalamberidze TD; Karpovich LG; Blokha VV; Bukovskaya NS
    Acta Virol; 1984 Sep; 28(5):388-94. PubMed ID: 6151352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentrated purified vaccine against tick-borne encephalitis. An immunological evaluation in experiments on mice].
    Khotlubeĭ LI; Pervikov IuV; Krutianskaia GL; Vil'ner LM; Semenov BF
    Vopr Virusol; 1982; 27(3):316-20. PubMed ID: 7123913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
    El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
    Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological status of people inoculated with various types of inactivated vaccine against tick-borne encephalitis].
    Pervikov IuV; El'bert LB; Krutianskaia GL; Belotskiĭ SM; Krasil'nikov IV
    Vopr Virusol; 1982; 27(6):696-701. PubMed ID: 7157778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new prospective vaccine against tick-borne encephalitis].
    Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of direct solid-phase immunoenzyme analysis for assessing the immunological activity of a vaccine against tick-borne encephalitis].
    Timofeev AV; El'bert LB; Terletskaia EN; Mal'dov DG; Karavanov AS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):89-93. PubMed ID: 3318250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.
    Kunz C; Heinz FX; Hofmann H
    J Med Virol; 1980; 6(2):103-9. PubMed ID: 7241091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentrated and purified vaccine against tick-borne encephalitis prepared by ultracentrifugation and chromatography].
    El'bert LB; Krasil'nikov IV; Drozdov SG; Grachev VP; Pervikov IuV
    Vopr Virusol; 1985; 30(1):90-3. PubMed ID: 3993007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation].
    El'bert LB; Gagarina AV; Khanina MK; Krutianskaia GL; Grachev VP
    Vopr Virusol; 1980; (3):341-5. PubMed ID: 7434727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis].
    Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD
    Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-immunological study of the effectiveness of vaccination against tick-borne encephalitis in the Maritime Territory].
    Leonova GN; Krugliak SP; Stepanova NM; Gorelikov VN
    Vopr Virusol; 1987; 32(2):225-8. PubMed ID: 3604187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals].
    Korovina GI; Titova TS; Churnosov EV
    Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
    Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
    Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.